サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1800749

アジア太平洋地域の次世代インターベンション心臓病市場：製品タイプ・適応症タイプ・エンドユーザー・国別の分析・予測 (2025-2035年)

Asia-Pacific Next-Generation Intervention Cardiology Market: Focus on Product Type, Indication Type, End User, and Country - Analysis and Forecast, 2025-2035

出版日
発行
BIS Research
ページ情報
英文 85 Pages
納期
1～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.34円
アジア太平洋地域の次世代インターベンション心臓病市場：製品タイプ・適応症タイプ・エンドユーザー・国別の分析・予測 (2025-2035年)
出版日: 2025年08月30日
発行: BIS Research
ページ情報: 英文 85 Pages
納期: 1～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域の次世代インターベンション心臓病の市場規模は、2024年の53億4,090万米ドルから、予測期間中はCAGR 8.46%で推移し、2035年には130億5,370万米ドルに達すると予測されています。

アジア太平洋の心臓医療は、次世代インターベンション心臓病によって変革されつつあります。これは、高度で低侵襲かつ精密に誘導された手技を用いて、構造的心疾患、冠動脈疾患、弁疾患を治療するものです。従来の開心術は、より安全で患者ごとに最適化されたカテーテル治療へと明確に移行しつつあります。安全性、正確性、手技の効率性を高めるため、アジア太平洋地域の医療従事者は、ロボティクス、AI駆動型イメージング、最先端の医療機器技術をますます活用しています。先端治療へのアクセス拡大、治療コストの削減、急速に進む高齢化や人口増加に伴う心血管疾患の有病率上昇への対応という、この地域の医療上の優先課題は、こうした進歩と一致しています。この進展は臨床転帰を改善し、回復時間を短縮する効果ももたらしています。

主要市場統計
予測期間 2025-2035年
2025年評価 56億9,180万米ドル
2035年予測 130億5,370万米ドル
CAGR 8.46%

同地域の次世代インターベンション心臓病の市場は、心血管疾患の有病率の上昇と低侵襲手技に対する需要の増加により、大きく拡大しています。韓国、中国、日本などの国における急速な高齢化に加え、インドや東南アジアでの生活習慣起因の心疾患リスクの増加により、従来の開心術に代わって高度なカテーテル治療が地域で広く普及しつつあります。

同地域の次世代インターベンション心臓病の市場では、ロボティクス、AI強化型イメージング、最先端デバイス技術が活用されており、精度の向上、合併症の減少、より迅速な回復を実現しています。地域の医療システムでは、薬剤溶出ステント、生体吸収性スキャフォールド、経カテーテル大動脈弁置換術 (TAVR) 、経カテーテル僧帽弁修復術 (TMVR) といった技術の導入が進んでいます。さらに、外来手術センター、ハイブリッドカテーテル検査室、デジタルヘルス統合の拡大によって、患者の先端治療へのアクセスも広がっています。

各国政府は、資金提供プログラム、有利な償還制度、インフラ投資を通じて、医療の近代化を積極的に推進しています。特に中国とインドでは、大規模な病院拡張が現在進行中です。医療アクセスの格差やコスト圧力といった課題は残されているものの、継続的な研究開発の取り組み、世界的な医療機器企業と地域企業とのパートナーシップ、患者の認知度向上が、同地域を次世代インターベンション心臓病の急成長市場として位置付けています。

市場セグメンテーション

セグメンテーション1：製品タイプ別

  • ロボティクス
    • ロボット支援経皮的冠動脈インターベンション (R-PCI)
    • ロボット支援冠動脈バイパス術 (RA-CABG)
    • ロボット支援僧帽弁置換術 (RMVR)
    • ロボット支援大動脈弁置換術
  • 非ロボティクス
    • IVUS
    • OCT
    • その他
      • ステント
      • カテーテル
      • ガイドワイヤー
      • PTCAバルーン
      • その他

セグメンテーション2：適応症タイプ別

  • 構造的心疾患
  • 冠動脈疾患
  • 心臓弁膜症
  • 末梢動脈疾患
  • 先天性心疾患

セグメンテーション3：エンドユーザー別

  • 病院・クリニック
  • 心臓センター
  • 外来手術センター

セグメンテーション4：地域別

  • アジア太平洋
    • 日本
    • インド
    • 中国
    • オーストラリア
    • 韓国
    • その他

当レポートでは、アジア太平洋地域の次世代インターベンション心臓病の市場を調査し、主要動向、市場影響因子の分析、法規制環境、技術・パイプラインの動向、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

範囲と定義

第1章 次世代インターベンション心臓病市場：業界展望

  • 競合情勢
    • 事業戦略
  • 次世代インターベンション心臓病市場：診断と管理
  • 冠動脈インターベンションの進歩
  • 冠動脈インターベンションにおける将来の方向性と新興技術
  • 次世代インターベンション心臓病市場におけるパイプライン製品
  • 規制状況
    • アジア太平洋

第2章 市場力学

  • 動向
    • 次世代インターベンション心臓病市場の動向
  • 市場力学
    • 動向、促進要因、課題、機会：現在および将来の影響評価
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 市場の課題

第3章 次世代インターベンション心臓病市場：地域別

  • 地域サマリー
  • アジア太平洋
    • 地域概要
    • 市場成長の原動力
    • 市場課題
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他

第4章 競合情勢と企業プロファイル

  • 企業プロファイル
    • Terumo Corporation

第5章 調査手法

図表

List of Figures

  • Figure 1: Asia-Pacific Next-Generation Intervention Cardiology Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Asia-Pacific Next-Generation Intervention Cardiology Market Snapshot
  • Figure 3: Asia-Pacific Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024, 2028, and 2035
  • Figure 4: Asia-Pacific Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024, 2028, and 2035
  • Figure 5: Asia-Pacific Next-Generation Intervention Cardiology Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 6: Cardiovascular Disease Statistics
  • Figure 7: Inclusion and Exclusion Criteria for Next-Generation Intervention Cardiology Market
  • Figure 8: Data Triangulation
  • Figure 9: Top-Down and Bottom-Up Approach
  • Figure 10: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Pipeline Products in Next-Generation Intervention Cardiology Market
  • Table 3: Next-Generation Intervention Cardiology Market (by Region), $Million, 2024-2035
  • Table 4: Asia-Pacific Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 5: Asia-Pacific Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 6: Asia-Pacific Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 7: Asia-Pacific Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 8: Asia-Pacific Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 9: Asia-Pacific Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 10: Asia-Pacific Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 11: Japan Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 12: Japan Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 13: Japan Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 14: Japan Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 15: Japan Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 16: Japan Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 17: Japan Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 18: China Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 19: China Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 20: China Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 21: China Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 22: China Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 23: China Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 24: China Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 25: India Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 26: India Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 27: India Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 28: India Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 29: India Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 30: India Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 31: India Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 32: Australia Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 33: Australia Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 34: Australia Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 35: Australia Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 36: Australia Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 37: Australia Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 38: Australia Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 39: South Korea Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 40: South Korea Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 41: South Korea Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 42: South Korea Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 43: South Korea Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 44: South Korea Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 45: South Korea Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 46: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 47: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 48: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 49: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 50: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 51: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 52: Rest-of-Asia-Pacific Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
目次
Product Code: BHL3210SS

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Next-Generation Intervention Cardiology Market

The Asia-Pacific next-generation intervention cardiology market is projected to reach $13,053.7 million by 2035 from $5,340.9 million in 2024, growing at a CAGR of 8.46% during the forecast period 2025-2035. Asian-Pacific (APAC) cardiac care is being revolutionized by next-generation interventional cardiology, which uses advanced, minimally invasive, precision-guided procedures to treat structural heart defects, coronary artery disease, and valvular illnesses. Traditional open-heart surgeries are clearly giving way to safer, more patient-specific catheter-based procedures around the region. In order to improve safety, accuracy, and procedural efficiency, healthcare professionals in Asia-Pacific are increasingly utilizing robotics, AI-driven imaging, and cutting-edge gadget technologies. The region's healthcare priorities of increasing access to cutting-edge therapies, lowering treatment costs, and addressing the rising prevalence of cardiovascular diseases in rapidly aging and growing populations are all in line with this advancement, which also improves clinical outcomes and speeds up recovery times.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$5,691.8 Million
2035 Forecast$13,053.7 Million
CAGR8.46%

Market Introduction

The market for next-generation interventional cardiology in Asia-Pacific (APAC) is expanding significantly due to the rising prevalence of cardiovascular illnesses and the growing need for minimally invasive procedures. Advanced catheter-based procedures are becoming more popular in the region as alternatives to traditional open-heart surgeries because to the rapidly aging populations in nations like South Korea, China, and Japan as well as the rising lifestyle-related cardiac risks in India and Southeast Asia.

Robotics, AI-enhanced imaging, and cutting-edge device technologies are all used in APAC's next-generation interventional cardiology to provide increased precision, fewer problems, and quicker recovery. The region's healthcare systems are increasingly implementing technologies including drug-eluting stents, bioresorbable scaffolds, transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve repair (TMVR). Furthermore, patient access to these cutting-edge treatments is being increased by the rise of ambulatory surgery centers, hybrid cath laboratories, and digital health integration.

With funding programs, advantageous reimbursement practices, and infrastructure expenditures, governments throughout Asia-Pacific are aggressively promoting healthcare modernization. This is especially true in China and India, where massive hospital expansions are currently taking place. While challenges such as disparities in healthcare access and cost pressures persist, continuous R&D efforts, partnerships between global medtech firms and local players, and increasing patient awareness are positioning APAC as a fast-emerging market for next-generation interventional cardiology.

Market Segmentation:

Segmentation 1: By Product Type

  • Robotics
    • Robotic-Assisted Percutaneous Coronary Intervention (R-PCI)
    • Robotic-Assisted Coronary Artery Bypass Grafting (RA-CABG)
    • Robotic Assisted Mitral Valve-Replacement (RMVR)
    • Robotic Assisted Aortic Valve Replacement
  • Non-Robotics
    • IVUS
    • OCT
    • Other Interventions
      • Stents
      • Catheters
      • Guidewires
      • PTCA Balloons
      • Others

Segmentation 2: By Indication Type

  • Structural Heart Disease
  • Coronary Heart Diseases
  • Valvular Heart Diseases
  • Peripheral Artery Diseases
  • Congenital Heart Diseases

Segmentation 3: By End User

  • Hospitals and Clinics
  • Cardiac Centers
  • Ambulatory Surgical Centers

Segmentation 4: By Region

  • Asia-Pacific
    • Japan
    • India
    • China
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific

APAC Next-Generation Intervention Cardiology Market Trends, Drivers and Challenges

Trends

  • Rapid shift from open-heart surgery to minimally invasive catheter-based procedures.
  • Growing adoption of robotics, AI-enhanced imaging, and 3D navigation in interventional cardiology.
  • Rising uptake of TAVR (Transcatheter Aortic Valve Replacement), TMVR (Transcatheter Mitral Valve Repair), bioresorbable scaffolds, and drug-coated balloons.
  • Expansion of hybrid cath labs and ambulatory surgical centers across urban and semi-urban regions.
  • Integration of digital health, telecardiology, and remote monitoring into cardiovascular care.
  • Increasing cross-border collaborations between global medtech firms and regional healthcare providers.

Drivers

  • High prevalence of cardiovascular diseases due to aging populations and lifestyle factors (e.g., diabetes, obesity, hypertension).
  • Rising healthcare investments in China, India, Japan, and South Korea to expand advanced cardiology services.
  • Strong push for healthcare modernization through government-funded programs and infrastructure expansion.
  • Growing patient awareness and demand for safer, faster, and less invasive treatment options.
  • Increasing medical tourism in APAC (particularly India, Thailand, and Singapore) for advanced cardiac procedures.

Challenges

  • Healthcare access disparities between urban and rural areas across APAC.
  • High procedure and device costs limiting widespread adoption in developing economies.
  • Complex regulatory environments and approval delays for next-gen medical devices.
  • Shortage of skilled interventional cardiologists and trained staff in emerging markets.
  • Reimbursement gaps and limited insurance coverage for advanced procedures in several countries.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in APAC next-generation intervention cardiology, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in APAC next-generation intervention cardiology and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to APAC next-generation intervention cardiology, ensuring organizations stay compliant and accelerate market entry for new next-generation intervention cardiology

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Table of Contents

Executive Summary

Scope and Definition

1 Next-Generation Intervention Cardiology Market: Industry Outlook

  • 1.1 Competitive Landscape
    • 1.1.1 Business Strategies
      • 1.1.1.1 Product Developments in Next-Generation Intervention Cardiology Market
  • 1.2 Next-Generation Intervention Cardiology Market: Diagnosis and Management
  • 1.3 Advancements in Coronary Intervention
  • 1.4 Future Direction and Emerging Technologies in Coronary Interventions
  • 1.5 Pipeline Products in the Next-Generation Intervention Cardiology Market
  • 1.6 Regulatory Landscape
    • 1.6.1 Asia-Pacific
      • 1.6.1.1 Japan
      • 1.6.1.2 China
      • 1.6.1.3 India

2 Market Dynamics

  • 2.1 Trends
    • 2.1.1 Trends in the Next-Generation Intervention Cardiology Market
      • 2.1.1.1 Shift towards Minimally Invasive and Percutaneous Procedures Transforming Treatment Paradigms
      • 2.1.1.2 Integration of AI-Predictive Intelligence in Intervention Cardiology
        • 2.1.1.2.1 AI in Imaging, Lesion Assessment, and Diagnostics
  • 2.2 Market Dynamics
    • 2.2.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 2.2.2 Market Drivers
      • 2.2.2.1 Rising Elderly Population, Driving Demand for Advanced Cardiac Interventions
        • 2.2.2.1.1 Cardiovascular Disease Burden in the Elderly
      • 2.2.2.2 Emergence of Robotic-Assisted Interventions- Enhancing Procedural Accuracy and Operator Control
    • 2.2.3 Market Restraints
      • 2.2.3.1 High Procedural Cost and Infrastructure Burden Limiting Broad Adoption
      • 2.2.3.2 Regulatory Complexity and Prolonged Approval Timelines Hindering Innovation
        • 2.2.3.2.1 Lengthy Approval Pathways for High-Risk Devices
        • 2.2.3.2.2 Lack of Harmonization across Geographies
        • 2.2.3.2.3 Regulatory Gaps for AI and Software-Driven Devices
    • 2.2.4 Market Opportunities
      • 2.2.4.1 Stent and Balloon Innovation Unlocking Next-Generation Use Cases
        • 2.2.4.1.1 Advancements in Drug-Coated Balloon Technologies
      • 2.2.4.2 Remote and Robotic-Enabled Expansion into Emerging Markets
        • 2.2.4.2.1 Bridging Access Gaps through Remote Robotics
    • 2.2.5 Market Challenges
      • 2.2.5.1 Data Standardization and Clinical Validation Gaps in AI-Driven Cardiology
      • 2.2.5.2 Safety and Clinical Validation Barriers for Next-Generation Vascular Implants

3 Next-Generation Intervention Cardiology Market (Region), Value ($million), 2024-2035

  • 3.1 Regional Summary
  • 3.2 Asia-Pacific
    • 3.2.1 Regional Overview
    • 3.2.2 Driving Factors for Market Growth
    • 3.2.3 Factors Challenging the Market
    • 3.2.4 Japan
    • 3.2.5 China
    • 3.2.6 India
    • 3.2.7 Australia
    • 3.2.8 South Korea
    • 3.2.9 Rest-of-Asia-Pacific

4 Competitive Landscape and Company Profiles

  • 4.1 Company Profiles
    • 4.1.1 Terumo Corporation
      • 4.1.1.1 Overview
      • 4.1.1.2 Top Products/Product Portfolio
      • 4.1.1.3 Top Competitors
      • 4.1.1.4 Target Customers
      • 4.1.1.5 Strategic Positioning and Market Impact
      • 4.1.1.6 Analyst View
      • 4.1.1.7 Pipeline and Research Initiatives

5 Research Methodology

  • 5.1 Data Sources
    • 5.1.1 Primary Data Sources
    • 5.1.2 Secondary Data Sources
    • 5.1.3 Inclusion and Exclusion
    • 5.1.4 Data Triangulation
  • 5.2 Market Estimation and Forecast